Summary of Study ST002713
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001681. The data can be accessed directly via it's Project DOI: 10.21228/M8DT5S This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
Study ID | ST002713 |
Study Title | Ranolazine induced metabolic rewiring improves melanoma responses to targeted therapy and immunotherapy - lipidomics |
Study Summary | Lipidomics analysis was performed on A375 melanoma cells resistant to BRAF inhibitor vemurafenib (VR) and cells resistant to VR and treated with fatty acid oxidation inhibitor ranolazine. |
Institute | University of Colorado Denver |
Last Name | Haines |
First Name | Julie |
Address | 12801 E 17th Ave, Room 1303, Aurora, Colorado, 80045, USA |
julie.haines@cuanschutz.edu | |
Phone | 3037243339 |
Submit Date | 2023-05-09 |
Raw Data Available | Yes |
Raw Data File Type(s) | raw(Thermo) |
Analysis Type Detail | LC-MS |
Release Date | 2023-06-21 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Factors:
Subject type: Cultured cells; Subject species: Homo sapiens (Factor headings shown in green)
mb_sample_id | local_sample_id | Treatment |
---|---|---|
SA273530 | A375P 4 | VEHICLE |
SA273531 | A375P 3 | VEHICLE |
SA273532 | A375P 1 | VEHICLE |
SA273533 | A375P 2 | VEHICLE |
SA273534 | A375 VR 4 | VEMURA |
SA273535 | A375 VR 3 | VEMURA |
SA273536 | A375 VR 2 | VEMURA |
SA273537 | A375 VR 1 | VEMURA |
SA273538 | A375 VR-Rano 4 | VEMURA+RANO |
SA273539 | A375 VR-Rano 2 | VEMURA+RANO |
SA273540 | A375 VR-Rano 1 | VEMURA+RANO |
SA273541 | A375 VR-Rano 3 | VEMURA+RANO |
Showing results 1 to 12 of 12 |